ES498305A0 - Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas. - Google Patents

Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas.

Info

Publication number
ES498305A0
ES498305A0 ES498305A ES498305A ES498305A0 ES 498305 A0 ES498305 A0 ES 498305A0 ES 498305 A ES498305 A ES 498305A ES 498305 A ES498305 A ES 498305A ES 498305 A0 ES498305 A0 ES 498305A0
Authority
ES
Spain
Prior art keywords
cleolos
specialty
nucleus
antibodies
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES498305A
Other languages
English (en)
Spanish (es)
Other versions
ES8206855A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of ES8206855A1 publication Critical patent/ES8206855A1/es
Publication of ES498305A0 publication Critical patent/ES498305A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES498305A 1980-01-04 1981-01-02 Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas. Granted ES498305A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000343088A CA1157373A (en) 1980-01-04 1980-01-04 Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s)

Publications (2)

Publication Number Publication Date
ES8206855A1 ES8206855A1 (es) 1982-08-01
ES498305A0 true ES498305A0 (es) 1982-08-01

Family

ID=4115973

Family Applications (2)

Application Number Title Priority Date Filing Date
ES498305A Granted ES498305A0 (es) 1980-01-04 1981-01-02 Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas.
ES509239A Expired ES8307377A1 (es) 1980-01-04 1982-02-01 Un procedimiento para detectar la localizacion del producto de reaccion antigeno-anticuerpoen la celulas malignas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES509239A Expired ES8307377A1 (es) 1980-01-04 1982-02-01 Un procedimiento para detectar la localizacion del producto de reaccion antigeno-anticuerpoen la celulas malignas.

Country Status (27)

Country Link
JP (1) JPS56101553A (ko)
KR (1) KR850001770B1 (ko)
AR (1) AR232046A1 (ko)
AT (1) AT373397B (ko)
AU (1) AU535024B2 (ko)
BE (1) BE886935A (ko)
CA (1) CA1157373A (ko)
CH (1) CH659328A5 (ko)
DE (1) DE3047654A1 (ko)
DK (1) DK554980A (ko)
ES (2) ES498305A0 (ko)
FI (1) FI810007L (ko)
FR (1) FR2484650B1 (ko)
GB (1) GB2067286B (ko)
GR (1) GR72850B (ko)
IE (1) IE50760B1 (ko)
IL (1) IL61641A (ko)
IT (1) IT1172216B (ko)
LU (1) LU83015A1 (ko)
NL (1) NL8007128A (ko)
NO (2) NO803910L (ko)
NZ (1) NZ195756A (ko)
OA (1) OA06713A (ko)
PH (5) PH18765A (ko)
PT (1) PT72301B (ko)
SE (1) SE450665B (ko)
ZA (1) ZA807754B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies
JPS5990052A (ja) * 1982-11-16 1984-05-24 Katsu Taniguchi モノクロ−ナル特異抗体を用いたメラノ−マ診断薬
US4746539A (en) * 1983-11-23 1988-05-24 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
EP0145373B1 (en) * 1983-11-23 1992-03-25 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4871661A (en) * 1983-11-23 1989-10-03 The Ohio State University Research Foundation Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment
US4645737A (en) * 1984-03-05 1987-02-24 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-treponemal antibodies
US4607008A (en) * 1984-03-05 1986-08-19 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies
EP0162977B1 (en) * 1984-05-02 1992-05-20 University Research Corporation Enzyme immunoassay for cancer procoagulant
US4616658A (en) * 1985-02-27 1986-10-14 William Shell Non-radioactively labeled microspheres and use of same to measure blood flow
US4798719A (en) * 1986-09-11 1989-01-17 University Of Pittsburgh Method for selection of antigens suitable as in vivo targets for antibodies
US5019368A (en) * 1989-02-23 1991-05-28 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
CA2023030A1 (en) * 1990-07-13 1992-01-14 Robert R. Guerrero In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals

Also Published As

Publication number Publication date
AR232046A1 (es) 1985-04-30
LU83015A1 (fr) 1981-06-04
PH18129A (en) 1985-03-22
FR2484650A1 (fr) 1981-12-18
IL61641A0 (en) 1981-01-30
SE450665B (sv) 1987-07-13
AT373397B (de) 1984-01-10
IT1172216B (it) 1987-06-18
DE3047654A1 (de) 1981-09-10
NO850005L (no) 1981-07-06
IT8167001A0 (it) 1981-01-05
IE802533L (en) 1981-07-04
DK554980A (da) 1981-07-05
BE886935A (fr) 1981-04-16
ES509239A0 (es) 1983-06-16
AU535024B2 (en) 1984-03-01
PH18637A (en) 1985-08-23
DE3047654C2 (ko) 1990-12-20
OA06713A (fr) 1982-06-30
PH18624A (en) 1985-08-21
GB2067286B (en) 1984-01-04
IL61641A (en) 1984-03-30
PH18636A (en) 1985-08-23
GR72850B (ko) 1983-12-07
FR2484650B1 (fr) 1985-06-21
PH18765A (en) 1985-09-20
ATA1081A (de) 1983-05-15
KR850001770B1 (ko) 1985-12-18
NZ195756A (en) 1983-11-18
NL8007128A (nl) 1981-08-03
ZA807754B (en) 1982-02-24
CH659328A5 (de) 1987-01-15
JPS56101553A (en) 1981-08-14
GB2067286A (en) 1981-07-22
PT72301A (en) 1981-01-01
SE8100011L (sv) 1981-07-05
NO803910L (no) 1981-07-06
PT72301B (en) 1981-11-10
ES8206855A1 (es) 1982-08-01
AU6507080A (en) 1981-07-09
CA1157373A (en) 1983-11-22
FI810007L (fi) 1981-07-05
ES8307377A1 (es) 1983-06-16
IE50760B1 (en) 1986-07-09
KR830003898A (ko) 1983-06-30

Similar Documents

Publication Publication Date Title
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
ES502722A0 (es) Procedimiento para la obtencion de preparados colorantes li-quidos concentrados y estables en almacenamiento
ES499103A0 (es) Procedimiento para la determinacion de glicerina
ES498305A0 (es) Un procedimiento para la preparacion de anticuerpos con especialidad frente a antigenos encontrados en los nucleos y nu-cleolos de las celulas humanas cancerosas.
ES546564A0 (es) Procedimiento para preparar anticuerpos monoclonales y deri-vados de los mismos
ES501195A0 (es) Procedimiento para la preparacion de imidosulfamidas antia- lergicas
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
AR223833A1 (es) Procedimiento para la preparacion de nuevos derivados antigenos
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES489480A0 (es) Mejoras en los aparatos para la fabricacion de cierres de cremallera
ES503449A0 (es) Procedimiento para la preparacion continua de alcoholes in- feriores
MX155128A (es) Procedimiento mejorado para la preparacion de derivados de melamina terminados en hidroxi
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES528897A0 (es) Un metodo para la preparacion de anticuerpos monoclonales humanos especificos para las celulas neoplasicas
ES500752A0 (es) Procedimiento para la preparacion de terpolimeros acrilicos
ES497006A0 (es) Procedimiento para producir laminados
ES491002A0 (es) Metodo mejorado para la propagacion in vitro de parasitos debabesia
ES505403A0 (es) Procedimiento para la determinacion de glicerina
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
AR231296A1 (es) Un procedimiento para la preparacion de 1-oxo-1h-tiazolo 3,2-a pirimidin-2-5-tetrazolil-carboxamida e intermediarios utilizados exclusivamente en dicho procedimiento
ES502356A0 (es) Procedimiento para preparar colorantes bisazoicos
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES500663A0 (es) Procedimiento para la preparacion de resinas poliaminoamidi-cas y poliaminoamidoimidazolinicas